Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We conducted a network meta-analysis to evaluate the efficacy and safety of oral antidiabetic drugs (OADs) for gestational diabetes. DATA SOURCES: We searched PubMed, the Cochrane Library, ClinicalTrials.gov, and related reviews from inception to October 2014. STUDY SELECTION: We included randomized clinical trials comparing efficacy and safety between different OADs or OADs vs insulin in patients with gestational diabetes. DATA SYNTHESIS: We included 18 randomized clinical trials. Traditional and network meta-analyses were performed to compare different OADs or OADs vs insulin. Traditional meta-analyses confirmed that there was no significant difference in maternal fasting blood glucose or glycated hemoglobin levels in patients treated with insulin, metformin, and glyburide. Compared to insulin, metformin was associated with lower maternal weight gain (weighted mean difference [WMD], -1.49 kg; 95% confidence interval [CI], -2.26 to -0.31), shorter gestational age (WMD, -0.16 wk; 95% CI, -0.30 to -0.03), and increased incidence of premature birth (odds ratio [OR], 1.63; 95% CI, 1.07 to 2.48). Compared to insulin, glyburide was associated with higher neonatal birth weight (WMD, 130.68 g; 95% CI, 55.98 to 205.38), increased incidence of neonatal hypoglycemia (OR, 2.64; 95% CI, 1.59 to 4.38), and increased incidence of macrosomia (OR, 3.09; 95% CI, 1.59 to 6.04). Network meta-analysis revealed that glyburide was associated with higher maternal weight gain, higher neonatal birth weight, increased incidence of neonatal hypoglycemia, and increased incidence of macrosomia than was metformin. CONCLUSION: Both metformin and glyburide are suitable for use in the management of gestational diabetes because of good glycemic control. However, glyburide treatment is associated with increased risk of neonatal hypoglycemia, high maternal weight gain, high neonatal birth weight, and macrosomia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Lowe, L. P., Metzger, B. E., Dyer, A. R., Lowe, J., McCance, D. R., Lappin, T. R. J., Trimble, E. R., Coustan, D. R., Hadden, D. R., Hod, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1687 · Cited by 367
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Wu, H.-Y., Huang, J.-W., Lin, H.-J., Liao, W.-C., Peng, Y.-S., Hung, K.-Y., Wu, K.-D., Tu, Y.-K., & Chien, K.-L. (2013) · BMJ · doi:10.1136/bmj.f6008 · Cited by 233
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“In the same meta-analyses, compared to metformin, glyburide use was associated with increased maternal weight gain, birthweight, macrosomia and neonatal hypoglycemia (361,362).”
Background13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
“Metformin was associated with a lower risk of neonatal hypoglycemia and less maternal weight gain than insulin in systematic reviews (46,49,50); however, metformin may slightly increase the risk of prematurity.”
Background15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Pharmacotherapy of type 2 diabetes: An update
Upadhyay, J., Polyzos, S. A., Perakakis, N., Thakkar, B., Paschou, S. A., Katsiki, N., Underwood, P., Park, K.-H., Seufert, J., Kang, E. S., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2017.08.010 · Cited by 187
13. Management of Diabetes in Pregnancy
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s016 · Cited by 179
Treatments for gestational diabetes: A systematic review and meta-analysis
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015557 · Cited by 163
Insulin for the treatment of women with gestational diabetes
Brown, J., Grzeskowiak, L., Williamson, K., Downie, M. R., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012037.pub2 · Cited by 158
Guo, L., Ma, J., Tang, J., Hu, D., Zhang, W., & Zhao, X. Q. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9804708 · Cited by 157
“’s study [14] including 18 RCTs revealed that both metformin and glyburide are suitable for use in the management of GDM, but glyburide was associated with more adverse pregnancy outcomes, including neonatal hypoglycemia, high maternal weight gain, high neonatal birth weight, and macrosomia.”
Background15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Nachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
“distress, neonatal hypoglycemia, birth injury, increased birth weight, large-forgestational-age neonate, and macrosomia (3,13,14,19).”
BackgroundSénat, M.-V., Affres, H., Letourneau, A., Coustols-Valat, M., Cazaubiel, M., Legardeur, H., Jacquier, J. F., Bourcigaux, N., Simon, E., Rod, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.4072 · Cited by 114
12. Management of Diabetes in Pregnancy
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s015 · Cited by 135
Diabesity and antidiabetic drugs
Pappachan, J. M., Fernandez, C. J., & Chacko, E. C. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.004 · Cited by 109
César, M. J. P., Molina‐Vega, M., Suárez-Arana, M., González‐Mesa, E., Sola-Moyano, A. P., Roldan-López, R., Romero-Narbona, F., Olveira, G., Tinahones, F. J., & González‐Romero, S. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.229 · Cited by 112
Al-Saeed, Y., Edwards, D. J., & Scaysbrook, S. J. (2020) · Construction Innovation · doi:10.1108/ci-12-2019-0141 · Cited by 107
Tsakiridis, I., Giouleka, S., Mamopoulos, A., Kourtis, A., Athanasiadis, A., Filopoulou, D., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000899 · Cited by 94
“04).(68) To date, long-term health data for the exposed to glyburide offspring are not available.”
BackgroundMetformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 101
“, 2015 [45] 18 RCTs, network meta-analysis.”
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 91
Role of Insulin in Placental Transport of Nutrients in Gestational Diabetes Mellitus
Ruíz‐Palacios, M., Ruiz‐Alcaraz, A. J., Sánchez-Campillo, M., & Larqué, E. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000455904 · Cited by 95
Medical Management of Diabesity: Do We Have Realistic Targets?
Pappachan, J. M., & Viswanath, A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0828-9 · Cited by 80
Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis
Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182488 · Cited by 73
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy
Dickens, L. T., & Thomas, C. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1147-0 · Cited by 83
Wu, S., Jin, J., Hu, K.-L., Wu, Y., & Zhang, D. (2022) · Nutrients · doi:10.3390/nu14122383 · Cited by 72
“Apprehension regarding the use of medications during pregnancy, for example, anxiety related to metformin crossing the placenta and reaching the fetus, also exists [46].”
BackgroundResultLiang, H.-L., Ma, S.-J., Xiao, Y.-N., & Tan, H.-Z. (2017) · Medicine · doi:10.1097/md.0000000000007939 · Cited by 57
“In 2014, one NMA([20]) including 18 RCTs revealed that both metformin and glyburide are suitable for use in the management of GDM, but glyburide was associated with more adverse pregnancy”
BackgroundMethodResultInfluentialPharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Malek, R., & Davis, S. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1187131 · Cited by 54
“, the meta-analysis [40] evaluating the efficacy and safety of OAD drugs for GDM, 457 glybur-”
BackgroundMethodYu, D., Xu, G., Teng, X., Xu, J., Tang, L., Feng, C., Rao, J., Jin, M., & Wang, L. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00865-9 · Cited by 56
Sheng, B., Ni, J., Lv, B., Jiang, G., Lin, X., & Li, H. (2023) · Acta Diabetologica · doi:10.1007/s00592-022-02016-5 · Cited by 50
Gestational diabetes mellitus: Multi-disciplinary treatment approaches
Kintiraki, E., & Goulis, D. G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.025 · Cited by 56
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 49
Behboudi‐Gandevani, S., Yarandi, R. B., Panahi, M. H., & Vaismoradi, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640004 · Cited by 52
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Wang, X., Liu, W., Chen, H., & Chen, Q. (2021) · Gynecologic and Obstetric Investigation · doi:10.1159/000515893 · Cited by 41
Self-citationProtective effect of metformin on a rat model of lipopolysaccharide‐induced preeclampsia
Hu, J., Zhang, J., & Zhu, B. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12501 · Cited by 38
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 41
“Other meta-analyses have noted similar findings of lower weight gain [55, 56], shorter gestational age [55, 56], and less pregnancy-induced hypertension [55, 56] with metformin compared to insulin; however, the data on preterm birth with metformin use has been conflicting, with some meta-analyses showing an increased…”
ResultPlows, J. F., Budin, F., Andersson, R., Mills, V., Macé, K., Davidge, S. T., Vickers, M. H., Baker, P. N., Silva‐Zolezzi, I., & Stanley, J. L. (2017) · Nutrients · doi:10.3390/nu9020141 · Cited by 33
“Another emerging treatment, sulfonylurea glyburide, carries similar unknowns [18,19].”
BackgroundPharmacological treatment of gestational diabetes mellitus: point/counterpoint
Langer, O. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.024 · Cited by 27
Affres, H., Sénat, M., Letourneau, A., Deruelle, P., Coustols-Valat, M., Bouchghoul, H., & Bouyer, J. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.002 · Cited by 21
Pharmacotherapy for gestational diabetes
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Papanas, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1509955 · Cited by 19
“gain, shorter gestational age, and less pregnancy-induced hypertension with metformin compared to insulin [70,71].”
BackgroundMusa, O. A. H., Syed, A., Mohamed, A. M., Chivese, T., Clark, J. M., Furuya‐Kanamori, L., Xu, C., Toft, E. S., Bashir, M., Abou‐Samra, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105546 · Cited by 27
Gayatri, V., Prasad, M. K., Mohandas, S., Nagarajan, S., Kumaran, K., & Ramkumar, K. M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176241 · Cited by 19
Bodier, L., Lous, M. L., Isly, H., Derrien, C., & Vaduva, P. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101622 · Cited by 21
Zhang, Y., Liu, X., Yang, L., & Zou, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596145 · Cited by 16
“Relevant clinical trials have reported that MET shows preventive effects on gestational hypertension and PE in pregnant women with high risks, including but not limited to pregestational diabetes mellitus (PGDM), GDM, PCOS, and obesity (Balsells et al., 2015; Jiang et al., 2015; Brownfoot et al., 2016; Syngelaki et al…”
BackgroundResearch progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“Therefore, to further understand the therapeutic effect of metformin on GDM, we summarized some studies on the control of blood glucose by metformin in pregnant women with GDM to further explore the effect of metformin on blood glucose in GDM in Table 1 (35-51).”
BackgroundResultInfluentialBowker, S. L., Savu, A., Yeung, R. O., Johnson, J. A., Ryan, E. A., & Kaul, P. (2017) · Diabetic Medicine · doi:10.1111/dme.13394 · Cited by 17
Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin
Zhen, X. M., Li, X., & Chen, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.002 · Cited by 17
Bouchghoul, H., Alvarez, J., Verstuyft, C., Bouyer, J., & Sénat, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232002 · Cited by 17
Sampaio, Y., Porto, L. B., Lauand, T. C. G., Marcon, L. P., & Pedrosa, H. C. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000310 · Cited by 15
“There are several studies examining oral antidiabetic drugs during pregnancy, mainly metformin and glibenclamide (18-20).”
BackgroundBougherara, L., Hanssens, S., Subtil, D., Vambergue, A., & Deruelle, P. (2018) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(18)88086-9 · Cited by 24
Ouyang, H., & Wu, N. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01142-7 · Cited by 16
Screening and management of major endocrinopathies during pregnancy: an update
Paschou, S. Α., Bletsa, E., Papazisi, M., Mili, N., Kanouta, F., Kassi, G., Ψαλτοπούλου, Θ., Goulis, D. G., & Lambrinoudaki, I. V. (2022) · Endocrine · doi:10.1007/s12020-022-03237-y · Cited by 14
Yarandi, R. B., Amiri, M., Tehrani, F. R., & Behboudi‐Gandevani, S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13603 · Cited by 17
Chaves, C., Cunha, F., Martinho, M., Garrido, S., Silva-Vieira, M., Estevinho, C., Melo, A., Figueiredo, O., Morgado, A., Almeida, M. C., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01665-8 · Cited by 12
Metformin Indications, Dosage, Adverse Reactions, and Contraindications
Stoica, R. A., Ștefan, D. S., Rizzo, M., Suceveanu, A., Suceveanu, A. P., Serafinceanu, C., & Stoian, A. P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88675 · Cited by 17
Controversies in Gestational Diabetes
Zera, C., & Seely, E. W. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.2.102 · Cited by 10
“These studies have also demonstrated less maternal weight gain associated with metformin than with glyburide.(65,66,71,73) A major limitation of both agents is the failure to achieve glycaemic control in many women with GDM.”
BackgroundResultInfluentialObesity: Molecular Mechanisms, Epidemiology, Complications and Pharmacotherapy
Jaberi, S. A., Cohen, A., Saeed, Z., Ojha, S. K., Singh, J., & Adeghate, E. A. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_13 · Cited by 10
Zhen, X. M., Li, X., & Chen, C. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.08.001 · Cited by 12
GESTATIONAL DIABETES MELLITUS: Challenges in diagnostics, management and impact
de Wit, L. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/195 · Cited by 9
Metformin in gestational diabetes mellitus
Tripathi, R., Tyagi, S., & Goel, V. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1572_16 · Cited by 8
Matallana, C. D. P., Blanco‐Carnero, J. E., Fernandez, M., Lewanczyk, M., Burton, M., Yang, X., Mitchell, A., Lövgren‐Sandblom, A., Marschall, H., Wright, D. E., et al. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101732 · Cited by 7
Metformin in Pregnancy for Women with Type 2 Diabetes: a Review
Benham, J. L., Donovan, L., & Yamamoto, J. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01409-0 · Cited by 8
“Results were mixed for neonatal outcomes for women with gestational diabetes randomly assigned to metformin compared with insulin alone with a reduction in neonatal hypoglycemia being reported in some [14, 15, 17], but not all [13, 16], meta-analyses.”
BackgroundMcCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Oral hypoglycemic agents: do the ends justify the means?
Langer, O. (2015) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-015-0021-6 · Cited by 5
Zegarra, R. R., DALL’ASTA, A., Revelli, A., & Ghi, T. (2022) · Nutrients · doi:10.3390/nu14173562 · Cited by 5
Gerbier, E., Favre, G., Maisonneuve, É., Ceulemans, M., Winterfeld, U., Dao, K., Schmid, C., Jenkinson, S. P., Niżnik, B., Baud, D., et al. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4105993 · Cited by 6
Игоревна, С. А., Esayan, E. R. M., Игоревна, К. О., & Gardanova, Z. R. (2016) · Diabetes Mellitus · doi:10.14341/dm2004126-29 · Cited by 5
Insulin Therapy in Gestational Diabetes
Stoian, A. P., Stoica, R. A., & Ștefan, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.84569 · Cited by 5
To Compare Metformin Vs Insulin in Gestational Diabetes in Terms of Neonatal Hypoglycemia
Mir, S., Saleem, R., Saghir, F., Mir, S. Z., Iqbal, A., & Manzoor, A. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115112928 · Cited by 5
Gestational diabetes mellitus management: diet and lifestyle
Allehdan, S., Basha, A. S., & Tayyem, R. (2020) · Nutrition & Food Science · doi:10.1108/nfs-03-2020-0095 · Cited by 5
Wang, T., Jing, Y., Guo, H., Xu, J., Wang, M., Huang, L., Chen, H., Cui, W., Song, L., Liu, X., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980578 · Cited by 6
Antidiabétiques oraux et grossesse
Sénat, M. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30120-7 · Cited by 7
Taylor, S. R. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.gdm_overview · Cited by 4
Zhang, Y., Yu, Z., Zhao, Y., Zou, L., Deng, B., & Liu, X. (2025) · Placenta · doi:10.1016/j.placenta.2025.03.020 · Cited by 3
Garvey, Z., Gupta, A., Taylor, N., Thirunavukkarasu, M., & Maulik, N. (2025) · Metabolites · doi:10.3390/metabo15030180 · Cited by 4
“Maternal weight gain is reduced with metformin rather than with insulin treatment [72,79,81].”
Feig, D. S. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110975 · Cited by 3
“Finally, a number of meta-analyses of RCTs in women with GDM comparing metformin use with insulin have shown a reduction in pregnancy-induced hypertension, maternal weight gain and neonatal hypoglycaemia, and some have shown a reduction in pre-eclampsia but these were not statistically significant.(1)”
BackgroundMetformin use in gestational diabetes
Campbell, I. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00018-7 · Cited by 3
Daud, N. A. A., Mohiuddin, S. G., Ong, Y. P., Yusof, F. A. M., Yusoff, F., Harun, S. N., & Ghadzi, S. M. S. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_542_20 · Cited by 3
“[6,14,16] Regarding the practice in managing GDM among the respondents, only 27% of the respondents had prescribed or dispensed metformin for GDM previously, especially when the patients were already treated for prepregnancy diabetes.”
Le diabète gestationnel : diagnostic et prise en charge
Meykiechel, T., Bourcigaux, N., & Christin‐Maître, S. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.05.002 · Cited by 8
IDF-MENA Region Guidelines for Management of Hyperglycemia in Pregnancy
Masood, S. N., Shegem, N. S., Baqai, S. M., Suliman, M. T., Alromaihi, D., Sultan, M. T. H., Salih, B. T., Ram, U., Ahmad, Z., Al-Jufairi, Z. A., et al. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_58_21 · Cited by 4
Ibraheem, E. Y., & Al-Karim, I. H. A. (2023) · Al-Kitab Journal for Pure Sciences · doi:10.32441/kjps.06.01.p3 · Cited by 2
“Wang X et al 2021[18] and Jiang YF et al 2015 [19] found that metformin was with lower neonatal birth weight, in which the results were the same as a previous study.”
ResultLiu, D., Chen, X., Wang, Q., Pan, X., Wei, X., Wang, B., Wang, Y., Xue, X., & Lu, C. (2025) · Precision medication. · doi:10.1016/j.prmedi.2025.100035 · Cited by 3
Self-citationWinardo, D. S., Wantania, J. J. E., & Mongan, S. P. (1970) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v8i1.1093 · Cited by 2
Antidiabéticos orais no diabetes gestacional: revisão de literatura
Araújo, P. H. D. A., Gregio, A. C. D. A. R., Scárdua, J. D. L. M., & Trindade, C. R. (2021) · Femina · doi:10.61622/0100-7254493202107 · Cited by 17
Infrasound Exposure: High-Resolution Measurements Near Wind Power Plants
Bakker, H. H. C., Alves‐Pereira, M., Mann, R., Summers, R., & Dickinson, P. (2023) · Environmental sciences · doi:10.5772/intechopen.109047 · Cited by 3
Review on pharmacological therapies for management of gestational diabetes
Shabnam, A., & Safia, B. (2023) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000047 · Cited by 2
A Metformina como opção terapêutica no diabetes mellitus gestacional: uma revisão de literatura
Klingelfus, A., Seabra, B. H. M., Techio, M. H. S., & Cruz, J. R. (2024) · Brazilian Journal of Development · doi:10.34117/bjdv10n8-029 · Cited by 1
Thakkar, S., Bhattacharya, S., Nagendra, L., Kapoor, N., Dutta, D., & Kalra, S. (2025) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2025.21.2.4 · Cited by 1
“51 A meta-analysis of 24 RCTs suggested that metformin reduced the risks of preeclampsia, induction of labour, caesarean delivery, neonatal hypoglycaemia, NICU admission, macrosomia and LGA infants.”
Hallack, C., Nogueira, B. V., Bomfim, M. D. L., Meireles, N. G., & Martins, W. P. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026rbgo18 · Cited by 1
“Fetal hypoglycemia was evaluated with the use of metformin alone, (8,13,32,33) with no differences from our findings.”
Pharmacotherapy of Gestational Diabetes Mellitus: Current Recommendations
Radenković, M., & Jakovljević, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100266 · Cited by 2
Abbas, S. H., & Khdair, S. A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00917 · Cited by 2
Rommy, Karinaningrum, A. D., Luthfiananda, B., Aniq, L., Evelina, L. S., & Fauzi, R. (2022) · Indonesian Journal of Pharmacology and Therapy · doi:10.22146/ijpther.3244 · Cited by 1
Current approaches in gestational diabetes mellitus
Peker, A., Yarkıcı, H., & Akar, H. (2019) · The European Research Journal · doi:10.18621/eurj.413973
“Metformin has been shown to increase risk of prematurity, although the risk of newborn hypoglycemia is lower, and the risk of maternal weight gain is reported to be less than insulin [35-37].”
BackgroundAcosta, M. E. H. (2018) · International Journal of Family & Community Medicine · doi:10.15406/ijfcm.2018.02.00096
Novosti u liječenju gestacijskog dijabetesa
Hlača, N., & Majanović, S. K. (2019) · Medicina Fluminensis · doi:10.21860/medflum2019_227123
Cordeiro, K. F., Matos, M. S., & Dytz, M. G. (2021) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2019.7592 · Cited by 1
Metadata
- Authors
- Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W.
- Affiliations
- Hebei University of Chinese Medicine (CN)
- Hebei Medical University (CN)
- Corresponding author
- Zhu, Zhong-Ning
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-05
- Volume
- 100
- Issue
- 5
- Pages
- 2071-2080
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2129155490
- Cited by
- 124
- References
- 35
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 8 · 2022: 9 · 2021: 40 · 2020: 12 · 2019: 7 · 2018: 15 · 2017: 15 · 2016: 3 · 2015: 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Hebei Province
- Department of Health of Hebei Province
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, oral antidiabetic drugs, metformin, glibenclamide, insulin therapy, neonatal hypoglycemia, macrosomia, birth weight, gestational weight gain, glycemic control, HbA1c, preterm birth, gestational age, drug safety comparison, drug efficacy comparison, network meta-analysis of randomized controlled trials
- MeSH terms
- Administration, Oral, Blood Glucose, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.